You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

HIV-1-infection

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

HIV-1-infection Trial (Low-dose STP0404 (Pirmitegravir), Medium-dose STP0404 (Pirmitegravir), High-dose STP0404 (Pirmitegravir))

Not yet recruiting
  • HIV-1-infection
  • Low-dose STP0404 (Pirmitegravir)
  • +3 more
  • (no location specified)
May 16, 2023

Multi-Drug Resistant Hiv-1 Infection, HIV-1 Infection Trial run by the National Institute of Allergy and Infectious Diseases

Not yet recruiting
  • Multi-Drug Resistant Hiv-1 Infection
  • HIV-1 Infection
  • UB-421
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Feb 2, 2023

HIV, HIV Pre-exposure Prophylaxis Trial (MK-8527, Placebo to MK-8527)

Not yet recruiting
  • HIV
  • HIV Pre-exposure Prophylaxis
  • (no location specified)
Sep 21, 2023

HIV-1-infection Trial (B/F/TAF)

Not yet recruiting
  • HIV-1-infection
  • (no location specified)
Oct 23, 2023

HIV Infection Trial (DOR/ISL)

Not yet recruiting
  • HIV Infection
  • (no location specified)
Mar 1, 2023

HIV-1-infection Trial in Shanghai, Kunming, Hangzhou (B/F/TAF, TDF-based triple ART regimen switching to B/F/TAF)

Recruiting
  • HIV-1-infection
  • B/F/TAF
  • TDF-based triple ART regimen switching to B/F/TAF
  • Shanghai, Shanghai, China
  • +2 more
Dec 1, 2022

Optimising Cohorts for HIV Cure Interventions

Recruiting
  • HIV-1-infection
  • no intervention
  • Prahran, Victoria, Australia
    Alfred Health
May 1, 2023

HIV-1-infection, HIV Seropositivity Trial in Gent (Leucapheresis)

Not yet recruiting
  • HIV-1-infection
  • HIV Seropositivity
  • Leucapheresis
  • Gent, Oost-Vlaanderen, Belgium
    UZ Gent
Jul 25, 2023

Observational PIC Destination Cohort

Not yet recruiting
  • HIV-1-infection
    • (no location specified)
    Aug 14, 2023

    HIV-1-infection Trial in Ghent (Dual versus triple therapy in treatment of HIV-1 infection.)

    Recruiting
    • HIV-1-infection
    • Dual versus triple therapy in treatment of HIV-1 infection.
    • Ghent, Belgium
      Ghent University Hospital
    Dec 5, 2022

    HIV Trial (Teropavimab, Zinlirvimab, Lenacapavir Tablet)

    Not yet recruiting
    • HIV Infections
    • Teropavimab
    • +4 more
    • (no location specified)
    Feb 6, 2023

    HIV-1-infection, Sexually Transmitted Diseases Trial in Madrid (Description)

    Completed
    • HIV-1-infection
    • Sexually Transmitted Diseases
    • Description
    • Madrid, Spain
      Hospital Universitario Infanta Leonor
    Aug 16, 2023

    HIV-1-infection, Metabolic Syndrome Trial (physical activity)

    Not yet recruiting
    • HIV-1-infection
    • Metabolic Syndrome
    • physical activity
    • (no location specified)
    Jun 6, 2023

    Pertussis Immunization During Pregnancy & HIV Infection

    Completed
    • Immunization; Infection
    • +3 more
    • TDaP
    • Brussels, Belgium
    • +1 more
    Sep 29, 2022

    Human Immunodeficiency Virus, HIV Trial (Islatravir, Placebo)

    Not yet recruiting
    • Human Immunodeficiency Virus
    • HIV
    • (no location specified)
    Oct 13, 2022

    Quantification of Antisense HIV RNA in Patients

    Recruiting
    • HIV-1-infection
    • Blood sampling
    • Paris, France
      Jean-Paul VIARD
    Dec 21, 2022

    HIV-1-infection Trial (Delstrigo, KOCITAF)

    Not yet recruiting
    • HIV-1-infection
    • (no location specified)
    Jun 20, 2023

    HIV-1-infection Trial in Liuzhou, Najing, Tianjin (B/F/TAF, TDF/3TC/EFV)

    Recruiting
    • HIV-1-infection
    • Liuzhou, Guangxi, China
    • +2 more
    Mar 31, 2022

    HIV-1 Infection Trial (DOR/ISL, BIC/FTC/TAF, Placebo to DOR/ISL)

    Not yet recruiting
    • HIV-1 Infection
    • (no location specified)
    Jan 20, 2023

    HIV-1-infection, HIV, HIV I Infection Trial (CAB + RPV)

    Not yet recruiting
    • HIV-1-infection
    • +2 more
    • CAB + RPV
    • (no location specified)
    Nov 16, 2022

    HIV-1-infection Trial (FMT capsules, Placebo capsules)

    Not yet recruiting
    • HIV-1-infection
    • FMT capsules
    • Placebo capsules
    • (no location specified)
    Aug 31, 2023

    HIV-1-infection Trial in Madrid (BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato)

    Completed
    • HIV-1-infection
    • BIC/FTC/TAF: Bictegravir/emtricitabina/tenofovir alafenamida fumarato
    • Madrid, Spain
      Hospital FUNDACIÓN JIMÉNEZ DÍAZ
    Nov 2, 2022

    HIV-infection/Aids Trial in Beijing (Bifidobacteria and Lactobacilli triple viable capsules)

    Recruiting
    • HIV-infection/Aids
    • Bifidobacteria and Lactobacilli triple viable capsules
    • Beijing, China
      Peking Union Medical College Hospital
    Mar 31, 2022

    HIV-1-infection, ART, Cd4+ Lymphocyte Deficiency Trial in Minneapolis (FT538, Vorinostat)

    Not yet recruiting
    • HIV-1-infection
    • +4 more
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 31, 2023

    Hiv, HIV-1-infection Trial in Buenos Aires (Lamivudine 300 MG, Emtricitabine / Tenofovir Disoproxil Pill)

    Active, not recruiting
    • Hiv
    • HIV-1-infection
    • Lamivudine 300 MG
    • Emtricitabine / Tenofovir Disoproxil Pill
    • Buenos Aires, Argentina
      Fundacion IDEAA
    Jan 2, 2023